Mobile-health Network Solutions Co-CEO Teoh Pui Pui Increases Equity Stake Through Open Market PurchaseNovember 17, 2025 4:30 PM EST | Source: Mobile-health Network SolutionsSingapore, Singapore--(Newsfile Corp. - November 17, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI HealthTech platform, today announced that its co-founder, co-CEO, COO, and Chairwoman of the Board, Dr. Teoh Pui Pui, has acquired additional shares of the company's Class A Or ...

Group 1 - LifeMD, Inc. will participate in the virtual BTIG Digital Health Forum on November 24, 2025, with a panel discussion focused on scalable virtual primary care and obesity health platforms [1] - The management will also be available for one-on-one virtual meetings during the forum [1][2] Group 2 - LifeMD is a leading provider of virtual primary care services, offering telemedicine, laboratory access, and pharmacy services across more than 200 conditions [3] - The company utilizes a vertically integrated digital care platform, a 50-state affiliated medical group, and a state-of-the-art compounding pharmacy to enhance access to quality care [3]

Core Insights - Mobile-health Network Solutions (MNDR) has formed a strategic partnership with Brands For Good Ltd (BFG) to enhance corporate wellness initiatives and promote social responsibility [1][2][4] - The partnership will provide BFG member companies with access to various healthcare services, including telemedicine, vaccinations, and health screenings, aimed at improving employee wellbeing [2][4] - MNDR's mission is to make healthcare accessible and affordable, aligning with BFG's commitment to recognizing businesses that contribute positively to their communities [3][4] Company Overview - Mobile-health Network Solutions is an AI-powered digital health platform based in Singapore, with operations expanding into the US and Southeast Asia [7] - The company offers telemedicine, AI-driven health tools, and virtual clinic infrastructure to enhance healthcare accessibility [7] Brands For Good Overview - Brands For Good Ltd is a non-profit organization focused on supporting companies that prioritize purpose and social impact in their business practices [8] - BFG nurtures a community of leaders who emphasize sustainability and ethical leadership, promoting responsible business as a catalyst for positive change [8]

Core Insights - The Medical Services sector is experiencing rapid transformation due to digital health advancements, value-based care adoption, and a focus on patient-centric solutions [1] - The global healthcare analytics market is projected to grow from $53.12 billion in 2024 to approximately $369.7 billion by 2034, with a CAGR of 21.4% [1] - The U.S. digital health market is expected to increase from about $145.9 billion in 2024 to $396.7 billion by 2028, reflecting a CAGR of 28.4% [4] Industry Overview - The Zacks Medical Services industry includes third-party service providers and caregivers, transitioning from volume-based to value-based care [3] - The resurgence in medical tourism is boosting the sector, necessitating advanced facilities and specialized external service providers [3] Trends Impacting the Industry - Digital Revolution: The increasing availability of unstructured health data and advanced analytics is driving the importance of big data in healthcare, with the global big data in healthcare market expected to grow from $78 billion in 2024 to $540 billion by 2035, at a CAGR of 19.20% [4] - Healthcare Staffing Shortage: A projected shortfall of over 100,000 healthcare workers by 2028, including 73,000 nursing assistants, is expected to elevate labor costs [2][5] - Revival in Nursing Care Market: Employment for nurse anesthetists, nurse midwives, and nurse practitioners is projected to grow 35% from 2024 to 2034, indicating high demand for specialized nursing roles [6] Current Industry Performance - The Medical Services Industry has underperformed compared to the Medical sector and the S&P 500, with a collective loss of 14.9% over the past year [10] - The industry is currently trading at a forward P/E of 15.1X, lower than the S&P 500's 23.7X and the sector's 20.1X [13] Company Highlights - Labcorp Holdings (LH): Expected earnings growth rate of 11.9% for 2025, with a revenue increase of 7.7% from 2024 [19][20] - Charles River Laboratories (CRL): Projected earnings growth rate of 4.9% for 2026, with revenue growth of 2.6% [23][24] - Teladoc Health (TDOC): Anticipated earnings growth rates of 80.1% for 2025 and 26.9% for 2026 [27][28]

Core Viewpoint - Lytus Technologies Holdings PTV. Ltd. plans to implement a reverse stock split at a ratio of 1-for-2,500 to increase the market price of its common shares and meet NYSE American listing requirements [1][3]. Group 1: Reverse Stock Split Details - The reverse stock split will take effect on September 26, 2025, and trading will commence on a split-adjusted basis under the existing symbol "LYTHF" [2]. - No fractional shares will be issued; any resulting fractional shares will be rounded up to the next whole number [4]. Group 2: Company Background - Lytus Technologies is a platform services company primarily operating in India, focusing on linear content streaming, telemedicine, and fintech [5]. - The company aims to consolidate its subscriber base for future technology services while enhancing its technology platform for improved service delivery [5].

Core Viewpoint - Lytus Technologies Holdings PTV. Ltd. plans to implement a reverse stock split at a ratio of 1-for-2,500 to increase the market price of its common shares and meet NYSE American listing requirements [1][3]. Company Announcement - The reverse stock split will take effect on September 26, 2025, and trading will commence on a split-adjusted basis under the existing symbol "LYTHF" [2]. - The new CUSIP number for the common shares post-split will be G5851A141 [2]. Purpose of the Reverse Stock Split - The primary goal of the reverse stock split is to enhance the market price of the shares, which is essential for the company to pursue uplisting to a national securities exchange [3]. Shareholder Information - VStock Transfer LLC will act as the transfer agent and will provide instructions to shareholders regarding the exchange of shares [3]. - Shareholders holding shares in book-entry form or brokerage accounts will not need to take any action for the exchange [3]. Fractional Shares - No fractional common shares will be issued; any resulting fractional shares will be rounded up to the next whole number [4]. Company Overview - Lytus Technologies Holdings PTV. Ltd. operates primarily in India, focusing on platform services, including linear content streaming and technology product development in telemedicine and fintech [5]. - The company aims to consolidate its subscriber base for future technology services while enhancing its technology platform for improved service delivery [5]. - Lytus is involved in various sectors, including digital streaming, HealthTech, fintech, AI, and cybersecurity, and operates in both domestic and international markets [5].

Company Overview - Mobile-health Network Solutions (MNDR) is a leading AI-powered digital healthcare platform provider headquartered in Singapore, with operations across Southeast Asia and plans to expand into the US [5] - The company offers telemedicine, AI-driven health tools, and virtual clinic infrastructure aimed at making healthcare accessible and intelligent through technology [5] Reverse Stock Split Announcement - MNDR announced a one-for-five reverse stock split effective at 12:01 a.m. Eastern Time on September 25, 2025, reducing the number of outstanding shares from approximately 4,684,779 to about 936,956 [1][2] - The number of authorized shares will decrease from 781,250,000 to 156,250,000, and the par value per share will change from $0.000032 to $0.00016 [2] Shareholder Communication and Process - VStock Transfer, LLC will act as the transfer agent, notifying stockholders of record and issuing post-split shares in paperless "book-entry" form [3] - Shareholders with certificated shares will receive instructions on how to surrender their certificates, while those holding shares in "street name" will have their positions automatically adjusted [3] Strategic Implications - The completion of the reverse stock split is seen as a significant advantage for MNDR in retaining its Nasdaq listing, which aligns with the company's strategic objectives [5]

Core Insights - Mobile-health Network Solutions (MNDR) has secured a strategic investment of US$900,000 from Indopacific Health Investment Corporation to enhance its growth strategy and market entry in Indonesia [1][3] - The investment follows an earlier subscription of US$150,000 in May 2025, bringing Indopacific's total investment in MNDR to US$1.05 million [3] - The funds will primarily be allocated for the acquisition of Lifepack, a digital pharmacy platform in Indonesia, and to support broader market initiatives across Southeast Asia [3][4] Investment Details - The share purchase was executed under a Securities Purchase Agreement dated September 10, 2025, with shares priced at US$1.80 each [2] - The transaction includes customary closing conditions and lock-up provisions in accordance with Nasdaq requirements [2] Company Overview - Mobile-health Network Solutions is an AI-powered digital health platform based in Singapore, with operations across Southeast Asia and plans to expand into the US [5] - The company focuses on providing telemedicine, AI-driven health tools, and virtual clinic infrastructure to enhance healthcare accessibility [5]

Core Insights - LifeMD, Inc. reported strong financial results for Q1 2025, achieving its first-ever quarter of GAAP profitability ahead of expectations [3][5] - The company experienced significant growth in telehealth services, with a 70% year-over-year increase in telehealth revenue [5][8] - LifeMD raised its full-year 2025 guidance for total revenues and adjusted EBITDA, reflecting robust performance in the telehealth segment [5][14] Financial Performance - Total revenues increased by 49% year-over-year to $65.7 million, with telehealth revenue contributing $52.5 million [8][9] - Adjusted EBITDA rose to $8.7 million from $0.1 million in the same period last year [9][30] - GAAP net income was reported at $0.6 million, or $0.01 per diluted share, compared to a net loss of $7.5 million, or ($0.19) per share, in Q1 2024 [9][21] Subscriber Growth - Telehealth active subscribers increased by 22% to approximately 290,000 [9][10] - Total active subscribers across all services reached 448,925, marking an 11% increase year-over-year [10] Strategic Initiatives - LifeMD expanded its service offerings, including the launch of men's hormone therapy and acceptance of Medicare, which are expected to enhance its telehealth platform [3][4] - The company formed strategic collaborations with LillyDirect and NovoCare to provide access to branded GLP-1 medications, positioning itself as a unique telehealth provider in the U.S. [4] Financial Guidance - For the full year 2025, LifeMD expects total revenues in the range of $268 million to $275 million, up from previous guidance of $265 million to $275 million [5][14] - Adjusted EBITDA guidance was raised to a range of $31 million to $33 million, reflecting strong year-to-date performance [5][14]